SCHEMBL30656383

SCHEMBL30656383

COC(=O)c1c(C(=O)O)sc2ccc(Br)cc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.52
MAPK1 P28482 1/20 0.52
L3MBTL1 Q9Y468 8/20 0.51
TDP1 Q9NUW8 3/20 0.51
ATM Q13315 3/20 0.45
UBE2N P61088 1/20 0.45
TLR9 Q9NR96 1/20 0.45
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
PFKFB3 Q16875 1/20 0.44
PFKFB4 Q16877 1/20 0.44
NR4A2 P43354 1/20 0.43
ALDH1A1 P00352 2/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26661127 1.00 LMNA (0.52) LMNAMAPK1L3MBTL1TDP1ATM
SCHEMBL31351348 0.91 LMNA (0.63) LMNAMAPK1L3MBTL1TDP1ATM
SCHEMBL26661107 0.91 LMNA (0.63) LMNAMAPK1L3MBTL1TDP1ATM
SCHEMBL26661110 0.89 LMNA (0.52) LMNAMAPK1L3MBTL1TDP1ATM
SCHEMBL26661116 0.83 LMNA (0.47) LMNAMAPK1L3MBTL1TDP1ATM
SCHEMBL30656361 0.83 LMNA (0.47) LMNAMAPK1L3MBTL1TDP1ATM
SCHEMBL11624275 0.80 LMNA (0.52) LMNAMAPK1ATMPFKFB3PFKFB4
SCHEMBL10958206 0.79 PFKFB3 (0.54) LMNAMAPK1L3MBTL1TDP1ATM
SCHEMBL20563093 0.79 MAPT (0.48) LMNAMAPK1L3MBTL1TDP1ATM
SCHEMBL25904738 0.79 LMNA (0.82) LMNAMAPK1L3MBTL1TDP1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP disclosed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed